Eli Net Income From Continuing Ops from 2010 to 2026
| LLY Stock | USD 1,041 31.79 3.15% |
Net Income From Continuing Ops | First Reported 2000-03-31 | Previous Quarter 5.6 B | Current Value 6.6 B | Quarterly Volatility 1.3 B |
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 974.3 M, Interest Expense of 835.1 M or Total Revenue of 68.4 B, as well as many indicators such as Price To Sales Ratio of 15.55, Dividend Yield of 0.0053 or PTB Ratio of 38.19. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
Eli | Net Income From Continuing Ops | Build AI portfolio with Eli Stock |
The evolution of Net Income From Continuing Ops for Eli Lilly and provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Eli Lilly compares to historical norms and industry peers.
Latest Eli Lilly's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Eli Lilly and over the last few years. It is Eli Lilly's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Eli Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 6,294,241,176 | |
| Coefficient Of Variation | 96.16 | |
| Mean Deviation | 4,002,267,820 | |
| Median | 4,637,900,000 | |
| Standard Deviation | 6,052,723,696 | |
| Sample Variance | 36635464.1T | |
| Range | 21.9B | |
| R-Value | 0.69 | |
| Mean Square Error | 20340965.7T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 829,973,039 | |
| Total Sum of Squares | 586167426.2T |
Eli Net Income From Continuing Ops History
About Eli Lilly Financial Statements
Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 20.6 B | 21.7 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.